Analysis of the MVM P38 Promoter Distal DNA cis-Elements Responsible for Transactivation by Nonstructural Proteins

  • Kim, Yoo-Nha (Department of Microbiology, Chungnam National University) ;
  • Ahn, Jeong-Keun (Department of Microbiology, Chungnam National University)
  • Received : 1996.07.26
  • Published : 1996.09.30


The P38 promoter of minute virus of mice (MVM) is a very weak promoter which is strongly transactivated by viral nonstructural proteins. To analyze the upstream sequence of the P38 promoter which is responsible for the transactivation by nonstructural proteins in MVM, chloramphenicol acetyltransferase (CAT) reporter plasm ids containing a series of 5' deletion and internal deletion mutants of the P38 promoter were constructed. The wild type and mutant CAT constructs of P38 promoter were cotransfected into murine A92L fibroblast cells with a plasmid expressing viral nonstructural proteins by DEAE-dextran method. Each promoter activity was analyzed by CAT assay. As previously reported (Ahn et al., 1992), the proximal DNA cis-elements required for transactivation of the MVM P38 promoter are GC box and TATA box. However, the analysis of 5' deletion mutants showed that H-l tar like sequence (MVM TAR) which is located between -143 and -122 relative to the transcription initiation site is also required for transactivation of the P38 promoter by nonstructural proteins. Interestingly, even if the MVM TAR was removed by internal deletion, the level of the transactivation is still 70% of wild type level of transactivation. We also found that, in addition to the MVM TAR motif, there are two other motifs which are similar to the MVM TAR sequence. When these TAR like motifs were further deleted, the levels of transactivation were decreased further. Taken together, the MVM TAR sequence and TAR like motifs located upstream of P38 promoter are playing an important role for the transactivation of P38 promoter by nonstructural proteins in minute virus of mice.


nonstructural proteins;MVM;MVM TAR sequence;P38 promoter;transactivation


  1. J. Virol. v.63 Ahn, J.K.;Gavin, B.J.;Kumar, G.;Ward, D.C.
  2. J. Virol. v.66 Ahn, J.K.;Pitluk, Z.W.;Ward, D.C.
  3. Nucleic Acids Res. v.11 Astell, C.R.;Thomson, M.;Merchlinsky, M.;Ward, D.C.
  4. J. Virol. v.52 Ben-Asher, E.;Aloni, Y.
  5. Anal. Biochem. v.72 Bradford, M.M.
  6. J. Virol. v.66 Brownstein, D.G.;Smith, A.L.;Johnson, E.A.;Pintel, D.J.;Naeger, L.K.;Tattersall, P.
  7. J. Virol. v.62 Clemens, K.E.;Pintel, D.
  8. J. Virol. v.64 Clemens, K.E.;Cerutis, R.;Burger, L.R.;Yang, C.Q.;Pintel, D.
  9. J. Virol. v.62 Cotmore, S.F.;Tattersall, P.
  10. J. Gen. Virol. v.69 Doerig, C.;Hirt, B.;Beard, P.;Antonietti, J.P.
  11. J. Virol. v.64 Li, X.;Rhode, S.L. III
  12. Nucleic Acids Res. v.12 Lopata, M.A.;Cleveland, D.W.;Sollner-Webb, B.
  13. J. Virol. v.47 Merchlinsky, W.J.;Tattersall, P.J.;Leary, J.L.;Cotmore, S.F.;Gardiner, E.M.;Ward, D.C.
  14. Virology v.188 Mario, H.S.;Salvino, R.;Leong, W.L.;Faust, E.A.
  15. J. Virol. v.60 Morgan, W.R.;Ward, D.C.
  16. J. Virol. v.64 Naeger, L.K.;Cater, J.;Pinter, D.J.
  17. Nucleic Acids Res. v.11 Pintel, D.;Dadachanji, D.;Astell, C.R.;Ward, D.C.
  18. J. Virol. v.61 Rhode, S.L. III;Richard, S.M.
  19. The Parvoviruses Siegel, G.;Bern, K.I.(ed.)
  20. J. Virol. v.46 Tattersall, P.;Bratton, J.